drugset / Trial / NCT06688292
The Safety and Effectiveness of Taneasy and Actein in COPD Patients
Phase 4
Completed
42 enrolled
Bun Yao Biotechnology Co., Ltd
KGS Pharmamate Co., Ltd · collabTaichung Veterans General Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of Taneasy 600mg granules and Actein effervescent tablets 600MG administered twice daily for 14 days in treatment of COPD Disease.
Timeline
- Start
- 2024-09-20
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Actein | Small molecule | 600 mg | — |
| Subject | Taneasy | Unknown | 600 mg | — |